Fluzoparib in Patients With Metastatic Non-clear Cell Renal Cell Carcinoma

NCT04535687 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

1

Enrollment

OTHER

Sponsor class

Conditions

Renal Cell Carcinoma

Interventions

DRUG: Fluzoparib

Sponsor

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School